Biomedical research has become a digital data-intensive endeavor, relying on secure and scalable computing, storage, and network infrastructure, which has traditionally been purchased, supported, and maintained locally. For certain types of biomedical applications, cloud computing has emerged as an alternative to locally maintained traditional computing approaches. Cloud computing offers users pay-as-you-go access to services such as hardware infrastructure, platforms, and software for solving common biomedical computational problems. Cloud computing services offer secure on-demand storage and analysis and are differentiated from traditional high-performance computing by their rapid availability and scalability of services. As such, cloud services are engineered to address big data problems and enhance the likelihood of data and analytics sharing, reproducibility, and reuse. Here, we provide an introductory perspective on cloud computing to help the reader determine its value to their own research.
Introduction
Progress in biomedical research is increasingly driven by insight gained through the analysis and interpretation of large and complex data sets. As the ability to generate and test hypotheses using high-throughput technologies has become technically more feasible and even commonplace, the challenge of gaining useful knowledge has shifted from the wet bench to include the computer. Desktop computers, high-performance workstations, and high-performance computing systems (HPC clusters) are currently the workhorses of the biomedical digital data research endeavor. Recently, however, cloud computing, enabled by the broad adoption and increasing capabilities of the internet and driven by market need, has emerged as a powerful, flexible, and scalable approach to disparate computational and data-intensive problems. The National Institute of Standards and Technology (NIST) states the following:
Cloud computing is a model for enabling convenient, on-demand network access to a shared pool of configurable computing resources (e.g., networks, servers, storage applications and services) that can be rapidly provisioned and released with minimal management effort or service provider interaction. a1111111111 a1111111111 a1111111111 a1111111111 a1111111111 Individual tools BLAST [10] is one of the most frequently used tools in bioinformatics research. A BLAST server image can be hosted on AWS, Azure, and GCP public clouds to allow users to run stand-alone searches with BLAST. Users can also submit searches using BLAST through the National Center for Biotechnology Information (NCBI) application programming interface (API) to run on AWS and Google Compute Engine [11] . Additionally, the Microsoft Azure platform can be leveraged to execute large BLAST sequence matching tasks within reasonable time limits. Azure enables users to download sequence databases from NCBI, run different BLAST programs on a specified input against the sequence databases, and generate visualizations from the results for easy analysis. Azure also provides a way to create a web-based user interface for scheduling and tracking the BLAST match tasks, visualizing results, managing users, and performing basic tasks [12] . CloudAligner is a fast and full-featured MapReduce-based tool for sequence mapping, designed to be able to deal with long sequences [13] , whereas CloudBurst [14] can provide highly sensitive short read mapping with MapReduce. High-throughput sequencing analyses can be carried out by the Eoulsan package integrated in a cloud IaaS environment [15] . For whole genome resequencing analysis, Crossbow [16] is a scalable software pipeline. Crossbow combines Bowtie, an ultrafast and memory efficient short read aligner, and SoapSNP, a genotyper, in an automatic parallel pipeline that can run in the cloud.
Workflows and platforms
Integration of genotype, phenotype, and clinical data is important for biomedical research. Biomedical platforms can provide an environment for establishing an end-to-end pipeline for data acquisition, storage, and analysis.
Galaxy, an open source, web-based platform, is used for data-intensive biomedical research [17] . For large scale data analysis, Galaxy can be hosted in cloud IaaS (see tutorial [18] ). Reliable and highly scalable cloud-based workflow systems for next-generation sequencing analyses has been achieved by integrating the Galaxy workflow system with Globus Provision [19] .
The Bionimbus Protected Data Cloud (BPDC) is a private cloud-based infrastructure for managing, analyzing, and sharing large amounts of genomics and phenotypic data in a secure environment, which was used for gene fusion studies [20] . BPDC is primarily based on OpenStack, open source software that provides tools to build cloud platforms [21] , with a service portal for a single point of entry and a single sign-on for various available BPDC resources. Using BPDC, data analysis for the acute myeloid leukemia (AML) resequencing project was rapidly performed to identify somatic variants expressed in adverse-risk primary AML samples [22] . Scalable and robust infrastructure for Next Generation Sequencing (NGS) analysis is needed for diagnostic work in clinical laboratories. CloudMan is available on the AWS cloud infrastructure [23] . It has been used as a platform for distributing tools, data, and analysis results. Improvements in using CloudMan for genetic variant analysis has been carried out by reducing storage costs for clinical analysis work [24] .
As part of the Pan Cancer Analysis of Whole Genomes (PCAWG), common patterns of mutation in over 2,800 cancer whole genome sequences were studied, which required significant scientific computing resources to investigate the role of the noncoding parts of the cancer genome and for comparing genomes of tumor and normal cells [25] . The PCAWG data coordinating center currently lists collaborative agreements with cloud provider AWS and the Cancer Collaboratory [26] , an academic compute cloud resource maintained by the Ontario Institute for Cancer Research and hosted at the Compute Canada facility.
Multiple academic resources were used to complete analysis of 1,827 samples taking over 6 months. This was supplemented by the use of cloud resources, where 500 samples were analyzed by AWS in 6 weeks [27] . This showed that public cloud resources can be rapidly provisioned to quickly scale up a project if increased compute resources are needed. In this instance, AWS S3 data storage was used to scale from 600 terabytes to multiple PBs. Raw reads, genome alignments, metadata, and curated data can also be incrementally uploaded to AWS S3 for rapid access by the cancer research community. Data search and access tools are also available for other researchers to use or reuse. Sequence read-level data and germline data are maintained at the controlled tier of the cloud, and access to read data requires preapproval from the International Cancer Genome Consortium (ICGC) data access compliance office.
The National Cancer Institute (NCI) has funded 3 cloud pilots to provide genomic analysis, computational support, and access capabilities to the Cancer Genome Atlas (TCGA) data [28] . The objective of the pilots was to develop a scalable platform to facilitate research collaboration and data reuse. All 3 cloud pilots have received authoritative and harmonized reference data sets from the cancer Genomic Data Commons (GDC) [29] that have been analyzed using a common set of workflows against a reference genome (e.g., GRCh38). The Broad Institute pilot developed FireCloud [30] using the elastic compute capacity of Google Cloud for largescale data analysis, curation, storage, and data sharing. Users can also upload their own analysis methods and data to workspaces and/or use Broad Institute's best practice tools and pipelines on preloaded data. FireCloud uses the Workflow Description Language (WDL) to enable users to run scalable, reproducible workflows [31] .
The Institute for Systems Biology (ISB) pilot leverages several services on the GCP. Researchers can use web-based software applications to interactively define and compare cohorts, examine the underlying molecular data for specific genes or pathways of interest, share insights with collaborators, and apply their individual software scripts and programs to various data sets [32] .
The ISB Cancer Genome Cloud (CGC) has loaded processed data and TCGA project metadata into the BigQuery managed database service, enabling easy data mining and data warehouse approaches to be used on large-scale genomics data. The Seven Bridges Genomics (SBG) CGC offers both genomics SaaS and PaaS and uses AWS [33] . The platform also enables researchers to collaborate on the analysis of large cancer genomics data sets in a secure, reproducible, and scalable manner. SGB CGC implements Common Work-Flow language [34] to facilitate developers, analysts, and biologists to deploy, customize, and run reproducible analysis methods. Users may choose from over 200 tools and workflows covering many aspects of genomics data processing to apply to TCGA data or their own data sets.
Efforts are underway by the NIH Center for Excellence in Big Data Computing at the University of Illinois, Urbana-Champaign to construct a Knowledge Engine for Genomics (KnowEnG). The KnowEnG system is deployed on a public cloud infrastructure-currently AWSto enable biomedical scientists to access data-mining, network-mining, and machine-learning algorithms that can aid in extracting knowledge from genomics data [35] . A massive knowledge base of community data sets called the Knowledge Network is at the heart of the KnowEnG system, and data sets, even those in spreadsheets, can be brought to KnowEnG for analysis.
Commercial (AWS, Microsoft Azure) cloud-based platforms (e.g., DNAnexus) enables analyses of massive amounts of sequencing data integrated with phenotypic or clinical information [36] . Also, the application of deep learning-based data analysis tools (e.g., Deep Variant) in conjunction with DNAnexus have been used to call genetic variants from next-generation sequencing data [37] . Other bioinformatics platforms (e.g., DNAstack) use the GCP for providing processing capability for over a quarter of a million whole human genome sequences per year [38] .
Healthcare
Cloud computing applications in healthcare include telemedicine/teleconsultation, medical imaging, public health, patient self-management, hospital management and information systems, therapy, and secondary use of data.
Real-time health monitoring for patients with chronic conditions who reside at considerable distances from their health service providers have difficulty in having their health conditions monitored. One poignant example are patients who suffer from cardiac arrhythmias requiring continuous episode detection and monitoring. Wearable sensors can be used for real-time electrocardiogram (ECG) monitoring, arrhythmia episode detection, and classification. Using AWS EC2, mobile computing technologies were integrated, and ECG monitoring capabilities were demonstrated for recording, analyzing, and visually displaying data from patients at remote locations. In addition, software tools that monitored and analyzed ECG data were made available via cloud SaaS for public use [39] . Also, the Microsoft Azure platform has been implemented for a 12-lead ECG telemedicine service [40] . For storage and retrieval of medical images, deployment of Picture Archive and Communication System modules were deployed in a public cloud [41] . A review of publications on cloud computing in healthcare has pointed out that many healthcare-related publications have used the term "cloud" synonymously with "virtual machines" or "web-based tools", not consistent with characteristics that define cloud computing, models, and services [42] . Several commercial vendors are interacting with hospitals and healthcare providers to establish healthcare services through cloud computing options.
General purpose tools
CloVR is a virtual machine that emulates a computer system, with preinstalled libraries and packages for biological data analysis [43] . Similarly, Cloud BioLinux is a publicly available resource with virtual machine images and provides over 100 software packages for high-performance bioinformatics computing [44] . Both (CloVR and BioLinux) virtual machine images are available for use within a cloud IaaS environment.
Cloud adoption can also include managed services that are designed for general Big Data problems. For example, each of the major public cloud providers offer a suite of services for machine learning and artificial intelligence, some of which are pretrained to solve common problems, (e.g., text-to-speech). Database systems such as Google BigQuery [45] and Amazon Redshift [46] combine the scalable and elastic nature of the cloud with tuned software and hardware solutions to deliver database capabilities and performance not easily achieved otherwise. For large, complex biomedical data sets, such databases can reduce management costs, ease database adoption, and facilitate analysis. Several big data applications used in biomedical research, such as the Apache Hadoop software library, are cloud based [47] .
Developing a cloud-based digital ecosystem for biomedical research
The examples introduced above, some ongoing for several years, illustrate a departure from the traditional approach to biomedical computing. The traditional approach has been to download data to local computing systems from public sites and then perform data processing, analysis, and visualization locally. The download time, cost, and redundancy involved for enhancing local computing capabilities to meet data intensive biomedical research needs (e.g., in sequencing and imaging) makes this approach worthy of re-evaluation.
Large-scale projects, like PCAWG introduced above, have shown the advantage of using resources, both local and public cloud, from various collaborating institutions. For institutions with established on-premises infrastructure (e.g., high-speed network infrastructure, secure data repositories), developing a cloud-based digital ecosystem with options to leverage any of the cloud types (public, hybrid) can be advantageous. Moreover, developing and utilizing a cloud-based ecosystem increases the likelihood of open science.
To promote knowledge discovery and innovation, open data and analytics should be findable, accessible, interoperable, and reusable (FAIR). The FAIR principles serve as a guide for data producers, stewards, and disseminators for enhancing reusability of data, inclusive of data algorithms, tools, and workflows that are essential for good data lifecycle management [48] . A biomedical data ecosystem should have capabilities for indexing of data, metadata, software, and other digital objects-a hallmark of the NIH Big Data to Knowledge (BD2K) initiative [49] .
Being FAIR is facilitated by an emerging paradigm for running complex, interrelated sets of software tools, like those used in genomics data processing, and involves packaging software using Linux container technologies, such as Docker, and then orchestrating "pipelines" using domain-specific workflow languages such as WDL and Common Workflow Language [34] . Cloud providers also provide batch processing (e.g., AWS Batch) capabilities that automatically provision the optimal quantity and type of compute resources based on the volume and specific resource requirements of the batch jobs submitted, thereby significantly facilitating analysis at scale.
In Fig 1, we illustrate integration of data producers, consumers, and repositories via a cloud-based platform for supporting the FAIR principles.
The core of a cloud-based platform should support the notion of a commons-a shared ecosystem maximizing access and reuse of biomedical research data and methods.
A cloud-based commons ecosystem can collocate computing capacity, storage resources, database, with informatics tools and applications for analyzing and sharing data by the research community. For multiple commons to interoperate with each other there are 6 essential requirements-permanent digital IDs, permanent metadata, APIs, data portability, data peering, and pay for compute [50] .
Other features of the ecosystem include indexing and search capabilities similar to DataMed [51] and a metalearning framework for ranking and selection of the best predictive algorithms [52] . Many of the bioinformatics software tools that we have discussed in the previous section have been successfully deployed in cloud environments and can be adapted to the commons ecosystem, including Apache Spark, a successor to Apache Hadoop and MapReduce for data analysis of Next Generation Sequencing Data [53] . In addition, the data transfer and sharing component of the cloud-based commons ecosystem can include features discussed for the Globus Research Data Management Platform [54] . We also envision cloud-based commons to be supported by techniques and methods that use a semantic data-driven discovery platform designed to continuously grow knowledge from a multitude of genomic, molecular, and clinical data [55] .
Security is an integral part of a cloud commons architecture along with data policy, governance, and a business case for sustaining a biomedical digital ecosystem. For initial security controls assessment, guidance documents such as Federal Information Security Management Act (FISMA), NIST-800-53, and Federal Information Processing Standards (FIPS) can provide tools for an organizational assessment of risk and for validation purposes [56, 57, 58] . Security in public cloud services is a shared responsibility, with the cloud provider providing security services and the end user maintaining responsibility for data and software that leverage those services. A wide range of issues involving ethical, legal, policy, and technical boundaries influence data privacy, all of which are dependent on the type of data being processed and supported [59] .
A regular training program for data users of the cloud, especially for handling sensitive data (e.g., personally identifiable information) is important. The training should include methods for securing data that is moved to the cloud, and controlling access to the cloud resources, including virtual machines, containers, and cloud services that are involved for data life cycle management. Protecting access keys, using multifactor authentication, creating identity and access management user lists with controlled permissions, following the principle of least privilege-configured to perform actions that are needed for the users-are some of the recommended practices that can minimize security vulnerabilities that could arise from inexperienced cloud users and/or from malicious external entities [54] .
Assessing risk is key to reliably determining the required level of protection needed for data in the cloud. A structured questionnaire approach developed as a Cloud Service Evaluation Model (CSEM) can be used to ascertain risks prior to migration of data to the cloud [60] . Based on the results of risk assessment, a suitable cloud deployment model can be chosen to ensure compliance with internal policies, legal, and regulatory requirements, which, externally, differ in different parts of the world, potentially impacting the ubiquitous nature of cloud resources.
Striving towards open biomedical data has motivated an interest in improving data access while maintaining security and privacy. For example, a community-wide open competition for developing novel genomic data protection methods has shown the feasibility of secure data outsourcing and collaboration for cloud-based genomic data analysis [61] . The findings from the work demonstrate that cryptographic techniques can support public cloud-based comparative analysis of human genomes. Recent work has shown that by using a hybrid cloud deployment model, 50%-70% of the read mapping task can be carried out accurately and efficiently in a public cloud [62] .
In summary, a cloud-based ecosystem requires capability for interoperability between clouds, development of tools that can operate in multiple cloud environments and that can address the challenges of data protection, privacy, and legal constraints imposed by different countries (see [63] for a discussion as it relates to genomic data).
Cloud advantages and disadvantages for biomedical projects
Cloud costs vary among biomedical projects and among vendors, so defining technical requirements for provisioning resources (e.g., amount of memory, disk storage, and CPU use) is an important first step in estimating costs. Remember the intent of commercial public cloud providers is to have you continue to use their cloud environment. For example, data may be free to upload but expensive to download, making adoption of commons approach in the cloud even more important for hosting large-scale biological data sets. This approach can meet community needs of data producers, consumers, and stewards (Fig 1) to improve access and minimize the need for downloading sets to local institutions. To test this approach, NIH has initiated a data commons pilot [64] by supporting the hosting of 3 important data sets, namely, Trans-Omics Precision Medicine initiative (TOPMed), Genotype Tissue Expression project (GTEx), and Alliance of Genomics Resource link, a consortium for Model Organism Databases (MODS) in the cloud.
Many cloud providers make available calculators for estimating approximate usage costs for their respective cloud services [65] . Without any point of reference to start with, estimating costs may be challenging. Commercial public cloud providers generally offer free credit with new accounts, which may be sufficient to kickstart the planning and evaluation process. Cloud service charges are based on exact usage in small time increments, whereas on site compute costs are typically amortized over 3-5-year periods for systems that can be used for multiple projects. Though cost comparisons between local infrastructure and cloud approaches are frequently sought, in practice, such comparisons are often difficult to perform effectively due to the lack of good data for actual local costs. Moreover, funding models for cloud computing differ among institutions receiving the funds and the funders themselves. For example, use of cloud resources may be subject to institutional overhead, whereas on-site hardware may not. This is not the best use of taxpayer money, and funding agencies should review their policies with respect to cloud usage by institutions charging overhead. Given the growing competitiveness in the cloud market, cloud resources may be negotiable or available under special agreements for qualifying research and education projects [66] [67] [68] .
Biomedical researchers in collaboration with IT professionals will need to determine the best way to leverage cloud resources for their individual projects [69] . Computing costs for using on premise infrastructure requires determining the total cost of ownership (TCO). Both direct and indirect costs contribute towards TCO. Direct costs include hardware purchase costs, network services, data center, electricity, software licenses, and salaries. Indirect costs typically include technical support services, data management, and training. Indirect institutional costs vary significantly depending on the complexity of the project. Productivity is a consideration when assessing costs. For example, a whole genome pipeline in a cloud environment, once prototyped, can be scaled up for processing entire genomes with subsequent minimal human cost [70] .
Using idle computing nodes in the cloud that are preemptible is one of the ways to reduce computing cost, but at the risk of increasing time to compute. For example, a recent report using the NCI cloud pilot ISB-CGC for quantification of transcript-expression levels for over 12,000 RNA-sequencing samples on 2 different cloud-based configurations, cluster-based versus pre-emptible, showed that the per sample cost when using the pre-emptible configuration was less than half the cost compared to the cluster-based method [71] .
Other approaches have used linear programming methods to optimally bid on and deploy a combination of underutilized computing resources in genomics to minimize the cost of data analysis [72] .
Cloud environments are pay-as-you-go, whereas research funding for computation is typically given at the beginning of an award and estimated on an annual basis. This can lead to a mismatch between the need for compute and the resources to meet that need. The NIH undertook a cloud credits pilot to assess an alternative funding model for cloud resources, details will be fully described in [73] . Credits were awarded when needed as opposed to up front, thereby matching usage patterns. A simple application and review mechanism available to a funded investigator means credits can typically be awarded in weeks or less. The investigator can choose with which cloud provider to spend the credits, thereby driving competition into the marketplace and presumably increasing the amount of compute that can be performed on research monies.
Cloud credits have focused on incentivizing cloud usage; however, a challenge that remains to be addressed is longer term data sustainability in cloud environments. The cost for data management and storage for retaining all the data produced during a research program can be prohibitive as collections become large. One of the ways to proactively tackle this issue is by engaging data producers, consumers, and curators from the beginning of the research data lifecycle process for developing value-based models for data retention, which can be implemented via cloud storage. Based on usage patterns, a policy driven data migration to least expensive cloud storage pools can be adopted. Our perspective is that long-term retention of biomedical data is an excellent venue for public and private institutions to partner together, to explore ways for co-ownership to manage cost and policy that can continue to make research data accessible over time.
Summary and conclusions
Cloud usage, from large-scale genomics analysis to remote monitoring of patients to molecular diagnostics work in clinical laboratories, has advantages but also potential drawbacks. A first step is the determination of what type of cloud environment best fits the application and then whether it represents a cost-effective solution. This introduction attempts to indicate what should be considered, what the options are, and what applications are already in use that may serve as references in making the best determination on how to proceed.
Cloud vendors provide multiple services for compute, storage, deployment of virtual machines, and access to various databases. Cloud vendors and third parties provide additional services to map users ranging from novices to experts. The ubiquitous nature of clouds raises questions regarding security and accessibility, particularly as it relates to geopolitical boundaries. Cost benefits of using clouds over other compute environments need to be carefully assessed as they relate to the size, complexity, and nature of the task. Clouds are termed elastic as they expand to embrace the compute needs of a task. For example, a simple, small prototype can be tested in a cloud environment and immediately scaled up to handle very large data. On the other hand, there is a cost associated with such usage, particularly in extricating the outcomes of the computation. Cloud vendors are seeking an all-in model. Once you commit to using their services, you continue to do so or pay a significant penalty. This, combined with being a pay-as-you-go model, has implications when mapped to the up-front funding models of typical grants. The idea of environments where multiple public cloud providers are used in a collective ecosystem is still mostly on the horizon. What is clear, however, is that clouds are a growing part of the biomedical computational ecosystem and are here to stay. 
